Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis-Reference-Cited by-同舟云学术

Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis

Published:2022-09-26 Issue:10 Volume:56 Page:1475-1485
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sharpton Suzanne R.¹²,Oh Tae Gyu³,Madamba Egbert²,Wang Chenjingyi⁴,Yu Ruth T.³,Atkins Annette R.³,Huan Tao⁴,Downes Michael³,Evans Ronald M.³,Loomba Rohit¹²⁵^ORCID

Affiliation:

1. Division of Gastroenterology Department of Medicine University of California San Diego La Jolla California USA

2. NAFLD Research Center, Department of Medicine University of California San Diego La Jolla California USA

3. Gene Expression Laboratory Salk Institute for Biological Studies La Jolla California USA

4. Faculty of Science, Department of Chemistry University of British Columbia Vancouver Canada

5. Division of Epidemiology, Department of Family Medicine and Public Health University of California San Diego La Jolla California USA

Funder

American Association for the Study of Liver Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Alcohol Abuse and Alcoholism

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17236

Reference34 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

4. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function

5. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A landscape of liver cirrhosis and transplantation in Mexico: changing leading causes and transplant as response;Annals of Hepatology;2024-09

2. Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment;Gut;2024-08-22

3. De Novo Cleaning of Chimeric MS/MS Spectra for LC-MS/MS-Based Metabolomics;Analytical Chemistry;2023-08-21

4. Bile Acid Alterations Characterize the Early Onset and Progression of Nonalcoholic Fatty Liver Disease in Young Mice Fed with High Fat and Fructose Diet;Molecular Nutrition & Food Research;2023-04-22

5. Global epidemiology of cirrhosis — aetiology, trends and predictions;Nature Reviews Gastroenterology & Hepatology;2023-03-28